Roxithromycin
Added to RFQ
For Research & Analytical Purposes. Not for Personal use.
Packaging & Handling
Indicative product packaging is shown for visual reference. Actual packaging may vary based on pack size, quantity, storage condition and shipping requirements.
Documentation Available
Detailed specifications, certificates, and supporting documents are available upon request.
Detailed specifications, certificates, and supporting documents are available upon request.
Storage: Refer MSDS for complete information.
Hazard: Refer MSDS for accurate information.
Roxithromycin Product Information
Roxithromycin is listed under API and is intended for analytical research, quality control and pharmaceutical reference standard applications. It is associated with Roxithromycin. The product is supplied by Clearsynth under CAT No. CS-O-30746.
Clearsynth provides this compound for research and analytical use, with product information including CAS number, molecular formula, molecular weight and product enquiry details.
Technical Data
Product Name
Roxithromycin
CAS No.
80214-83-1
CAT No.
CS-O-30746
HSN Code
38229010
Country of Origin
Can be shipped from India, Canada and USA
Molecular Formula
C41H76N2O15
Molecular Weight
837.05
Category
API Family
Storage Condition
Refer MSDS for complete information.
Hazard Compound
Refer MSDS for accurate information.
Description
Regulatory Description
Roxithromycin is supplied with detailed characterization data compliant with regulatory guideline. Roxithromycin can be used for analytical method development, method validation (AMV), Quality Control (QC) application for Abbreviated New Drug Application (ANDA), or during commercial production of Roxithromycin.
Overview
"Semisynthetic derivative of erythromycin and concentrated by human phagocytes and is bioactive intracellularly. While the drug is active against a wide spectrum of pathogens, it is effective in the treatment of respiratory and genital tract infections."
Synonyms
Roxithromycin
Application Notes
"Semisynthetic derivative of erythromycin and concentrated by human phagocytes and is bioactive intracellularly. While the drug is active against a wide spectrum of pathogens, it is effective in the treatment of respiratory and genital tract infections."
Product Applications & Regulatory Search Terms
Useful product, supplier and regulatory search terms for this reference standard.